← Leaderboards
Matthew R Taylor
University Of Colorado Denver
$5,502,265
Attributed
$8,227,588
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,227,588 · 5
By mechanism
R01$7,574,447 · 4
K23$653,141 · 1
Top collaborators
- Luisa Mestroni9 shared
- Ani Wang Manichaikul2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Luisa Mestroni$6,229,262
- Brian L Stauffer$5,871,842
- Michael R. Bristow$7,111,960
- Kathryn C. Chatfield$1,499,821
- Brian D Lowes$1,893,454
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesCardiomyopathiesGeneticMutationVariantDesignHeart FailureGenomicsDilated CardiomyopathyGenetic VariantNovel TherapeuticsGenome SequencingResearch PersonnelClinical DataCohortUnited States National Institutes Of HealthRegistriesInnovationCardiac MyocytesBaseHeartPathway InteractionsAffectCardiac
Grant awards (25)
Elucidating the Origin of Sudden Cardiac Death in Dilated Cardiomyopathy: from Phenotype Predictors to Therapeutic Targets$679,139
R01 · FY2025 · HL
Integrative genomic and transcriptomic investigation of human heart failure mechanisms$631,780
R01 · FY2025 · HL · contact PI
Elucidating the Origin of Sudden Cardiac Death in Dilated Cardiomyopathy: from Phenotype Predictors to Therapeutic Targets$22,495
R01 · FY2025 · HL
Elucidating the Origin of Sudden Cardiac Death in Dilated Cardiomyopathy: from Phenotype Predictors to Therapeutic Targets$675,327
R01 · FY2024 · HL
Integrative genomic and transcriptomic investigation of human heart failure mechanisms$624,142
R01 · FY2024 · HL · contact PI
Engineering Cardiac spheroids to study Laminopathies$37,732
R01 · FY2024 · HL
Elucidating the Origin of Sudden Cardiac Death in Dilated Cardiomyopathy: from Phenotype Predictors to Therapeutic Targets$727,280
R01 · FY2023 · HL
Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathy$508,747
R01 · FY2023 · HL
Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathy$510,302
R01 · FY2022 · HL
Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathy$509,525
R01 · FY2021 · HL
Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathy$524,177
R01 · FY2020 · HL
Whole genome DNA sequencing to identify novel genes in dilated cardiomyopathy$410,109
R01 · FY2016 · HL · contact PI
Whole genome DNA sequencing to identify novel genes in dilated cardiomyopathy$429,571
R01 · FY2015 · HL · contact PI
Whole genome DNA sequencing to identify novel genes in dilated cardiomyopathy$391,713
R01 · FY2014 · HL · contact PI
Whole genome DNA sequencing to identify novel genes in dilated cardiomyopathy$37,713
R01 · FY2014 · HL · contact PI
Whole genome DNA sequencing to identify novel genes in dilated cardiomyopathy$20,984
R01 · FY2014 · HL · contact PI
Whole genome DNA sequencing to identify novel genes in dilated cardiomyopathy$385,715
R01 · FY2013 · HL · contact PI
Whole genome DNA sequencing to identify novel genes in dilated cardiomyopathy$39,086
R01 · FY2013 · HL · contact PI
Whole genome DNA sequencing to identify novel genes in dilated cardiomyopathy$384,375
R01 · FY2012 · HL · contact PI
Whole genome DNA sequencing to identify novel genes in dilated cardiomyopathy$24,535
R01 · FY2012 · HL · contact PI
Familial Dilated Cardiomyopathy:Genetic Characterization$130,680
K23 · FY2006 · HL · contact PI
Familial Dilated Cardiomyopathy:Genetic Characterization$130,680
K23 · FY2005 · HL
Familial Dilated Cardiomyopathy:Genetic Characterization$130,661
K23 · FY2004 · HL
Familial Dilated Cardiomyopathy:Genetic Characterization$130,584
K23 · FY2003 · HL
Familial Dilated Cardiomyopathy:Genetic Characterization$130,536
K23 · FY2002 · HL